Vireo Growth Common Stock Net 2023-2025 | VREOF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Vireo Growth common stock net from 2023 to 2025. Common stock net can be defined as the value of common equity ownership.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Vireo Growth common stock net from 2023 to 2025. Common stock net can be defined as the value of common equity ownership.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$218.6B
Boston Scientific (BSX)	$157.1B
Stryker (SYK)	$151.4B
EssilorLuxottica (ESLOY)	$135B
Medtronic (MDT)	$118.4B
Lonza Group Ag (LZAGY)	$50B
Haleon (HLN)	$44.2B
ResMed (RMD)	$40.1B
GE HealthCare Technologies (GEHC)	$35.2B
Agilent Technologies (A)	$34.2B
Terumo (TRUMY)	$26B
Koninklijke Philips (PHG)	$24.9B
Insulet (PODD)	$20.2B
Zimmer Biomet Holdings (ZBH)	$19.2B
Baxter (BAX)	$14.8B
Smith & Nephew SNATS (SNN)	$13.8B
Sunny Optical Technology (SNPTF)	$10.4B
Demant (WILYY)	$8.6B
Bio-Rad Laboratories (BIO)	$7.1B
Lantheus Holdings (LNTH)	$4.9B
Perrigo (PRGO)	$3.9B
Prestige Consumer Healthcare (PBH)	$3.8B
Haemonetics (HAE)	$3.6B
Envista Holdings (NVST)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
ICU Medical (ICUI)	$3.2B
LeMaitre Vascular (LMAT)	$1.8B
QuidelOrtho (QDEL)	$1.8B
AtriCure (ATRC)	$1.5B
Acuren (TIC)	$1.5B